(1.26%) 5 127.79 points
(1.18%) 38 676 points
(1.99%) 16 156 points
(-1.22%) $77.99
(5.65%) $2.15
(0.02%) $2 310.10
(-0.16%) $26.79
(0.37%) $966.20
(-0.35%) $0.929
(-1.07%) $10.87
(-0.11%) $0.797
(0.36%) $91.45
4 days till quarter result
(bmo 2024-05-08)
Expected move: +/- 8.69%
-7.63% $ 2.30
Live Chart Being Loaded With Signals
Finch Therapeutics Group, Inc., a clinical-stage microbiome therapeutics company, develops a novel class of orally administered biological drugs in the United States...
Stats | |
---|---|
Dzisiejszy wolumen | 53 317.00 |
Średni wolumen | 47 069.00 |
Kapitalizacja rynkowa | 3.69M |
EPS | $0 ( 2024-03-28 ) |
Następna data zysków | ( $0 ) 2024-05-08 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -0.0500 |
ATR14 | $0.0560 (2.43%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-03-28 | Smisek Jeffery A | Sell | 1 600 | Common Stock |
2024-03-28 | Smisek Jeffery A | Sell | 6 642 | Common Stock |
2023-11-22 | Smisek Jeffery A | Sell | 1 470 | Common Stock |
2023-06-09 | Blischak Matthew P. | Buy | 962 899 | Stock Option (right to buy) |
2023-06-08 | Blischak Matthew P. | Buy | 962 899 | Stock Option (right to buy) |
INSIDER POWER |
---|
97.82 |
Last 84 transactions |
Buy: 22 938 760 | Sell: 28 923 806 |
Finch Therapeutics Group, Korelacja
10 Najbardziej pozytywne korelacje | |
---|---|
ACET | 0.917 |
VNDA | 0.917 |
AFMD | 0.914 |
COMT | 0.91 |
GROM | 0.903 |
EQRX | 0.889 |
STRC | 0.889 |
VRAY | 0.886 |
KSPN | 0.885 |
AYLA | 0.883 |
10 Najbardziej negatywne korelacje | |
---|---|
ROVR | -0.879 |
NVCN | -0.878 |
FTIV | -0.876 |
TIOAU | -0.873 |
XM | -0.873 |
ATVI | -0.873 |
BHAC | -0.868 |
IDLB | -0.867 |
APXI | -0.867 |
PAYA | -0.867 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Finch Therapeutics Group, Korelacja - Waluta/Towar
Finch Therapeutics Group, Finanse
Annual | 2023 |
Przychody: | $107 000 |
Zysk brutto: | $-1.41M (-1 320.56 %) |
EPS: | $-46.59 |
FY | 2023 |
Przychody: | $107 000 |
Zysk brutto: | $-1.41M (-1 320.56 %) |
EPS: | $-46.59 |
FY | 2022 |
Przychody: | $861 000 |
Zysk brutto: | $-4.65M (-539.61 %) |
EPS: | $-71.52 |
FY | 2021 |
Przychody: | $18.53M |
Zysk brutto: | $18.53M (100.00 %) |
EPS: | $-1.676 |
Financial Reports:
No articles found.
Finch Therapeutics Group,
Finch Therapeutics Group, Inc., a clinical-stage microbiome therapeutics company, develops a novel class of orally administered biological drugs in the United States. The company's lead candidate is CP101, an orally administered microbiome capsule that is in Phase 3 clinical trial for the treatment of patients with recurrent Clostridioides difficile infection, as well as for the treatment of chronic hepatitis B virus. It is also developing FIN-211, an orally administered enriched consortia product candidate for use in the treatment of autism spectrum disorder; and TAK-524 and FIN-525, which are orally administered targeted consortia product candidates for the treatment of ulcerative colitis and Crohn's disease. The company has collaboration and license agreements with Takeda Pharmaceutical Company Limited; Skysong Innovations LLC; and University of Minnesota. Finch Therapeutics Group, Inc. was incorporated in 2014 and is based in Somerville, Massachusetts.
O Sygnały na żywo
Prezentowane na tej stronie sygnały na żywo pomagają określić, kiedy KUPIĆ lub SPRZEDAĆ BRAK DANYCH. Sygnały mogą mieć opóźnienie wynoszące nawet 1 minutę; jak wszystkie sygnały rynkowe, istnieje ryzyko błędu lub pomyłki.
Sygnały transakcyjne na żywo nie są ostateczne i getagraph.com nie ponosi odpowiedzialności za żadne działania podjęte na podstawie tych sygnałów, jak opisano w Warunkach Użytkowania. Sygnały opierają się na szerokim zakresie wskaźników analizy technicznej